Menu

  • Cardiac Diagnostics & Monitoring
  • Conditions
  • Clinical Evidence
  • Resources
  • Reimbursement

    • The PICTURE study1

    Reveal™ ICMs guide diagnosis in 78% of patients with a recurrent syncopal event.

    The PICTURE study investigated the effectiveness of Reveal™ ICMs in the diagnosis of unexplained, recurrent syncope in everyday clinical practice, and helped inform current syncope guidelines.2

    Study design1

    • 570 patients analyzed
    • Patient eligibility: enrolled patients had recurrent unexplained syncope or pre-syncope
    • Patients received a Reveal™ ICM
    • Patients were followed up until the first syncopal recurrence, or for at least one year

    Key findings1

    570 patients enrolled

    38%

    of patients experienced a recurrence within one year.

    218 patients

    78%

    of patients had a Reveal™ ICM-guided diagnosis.1

    170 patients

    75%

    of patients were diagnosed with a cardiac cause.

    128 patients

    25%

    of patients were confirmed to have a noncardiac issue.

    42 patients

    Physician specialists consulted before ICM insertion

    Clinical impact1

    PICTURE study found that syncope patients:

    • Moved from specialist to specialist without answers
    • Had a median of 13 inconclusive tests before a Reveal™ ICM was implanted
    • 70% were hospitalized at least once for syncope and of that, one third experienced significant trauma

    By using ICMs earlier in the care pathway, there is the potential to reduce the number of physicians patients see.

    Study conclusion1

    ICMs should be implanted earlier rather than later in the evaluation of unexplained syncope.

    Related products